Note 5 - License Agreements (Details)	1 Months Ended	3 Months Ended		45 Months Ended				0 Months Ended	3 Months Ended	1 Months Ended			3 Months Ended		45 Months Ended				1 Months Ended								0 Months Ended							3 Months Ended
	Mar. 31, 2011 USD ($)	Mar. 31, 2014 USD ($)	Mar. 31, 2013 USD ($)	Mar. 31, 2014 USD ($)	Feb. 24, 2014	Apr. 03, 2014 Subsequent Event [Member] Patent Coverage Available [Member] Dalhousie University [Member]	Apr. 03, 2014 Subsequent Event [Member] Data Protection Available [Member] Dalhousie University [Member]	Apr. 03, 2014 Subsequent Event [Member] Dalhousie University [Member] USD ($)	Mar. 31, 2014 Achievement of Milestoe Marks [Member] iCo [Member] USD ($)	Jun. 30, 2011 Ordinary Shares [Member] iCo [Member] USD ($)	Jun. 30, 2011 iCo [Member] Cash Payment [Member] USD ($)	Jun. 30, 2011 iCo [Member] Exclusive License Rights [Member] USD ($)	Mar. 31, 2014 iCo [Member] USD ($)	Mar. 31, 2013 iCo [Member] USD ($)	Mar. 31, 2014 iCo [Member] USD ($)	Dec. 31, 2013 iCo [Member] USD ($)	Jun. 30, 2011 iCo [Member] USD ($)	Mar. 31, 2014 iCo [Member] From inception [Member]	Apr. 30, 2011 Yissum [Member] License Maintenance Fee [Member] USD ($)	Apr. 30, 2011 Yissum [Member] Max Amount of Maintenance Fee Year One - Year Six [Member] USD ($)	Apr. 30, 2011 Yissum [Member] Research Fee [Member] USD ($)	Apr. 30, 2011 Yissum [Member] Research Fees year 2-6 [Member] USD ($)	Apr. 30, 2011 Yissum [Member] Aggregate Research Fees, Maximum [Member] USD ($)	Apr. 30, 2011 Yissum [Member] USD ($)	Mar. 31, 2011 Kadouche [Member] Cash Payment [Member] USD ($)	Mar. 31, 2011 Kadouche [Member] Exclusive License Rights [Member] USD ($)	May 02, 2012 Lonza [Member] Annual Payments - License Cost [Member] USD ($)	May 02, 2012 Lonza [Member] Annual Payments - License Cost [Member] GBP (£)	May 02, 2012 Lonza [Member] Annual Payments, Sublicense [Member] USD ($)	May 02, 2012 Lonza [Member] Annual Payments, Sublicense [Member] GBP (£)	May 02, 2012 Lonza [Member] Cell Line Payments [Member] USD ($)	May 02, 2012 Lonza [Member] Cell Line Payments [Member] GBP (£)	May 02, 2012 Lonza [Member]	Mar. 31, 2014 Shire BioChem (Member) USD ($)
Note 5 - License Agreements (Details) [Line Items]
License Costs											$ 500,000	$ 1,700,000							$ 30,000	$ 100,000	$ 400,000	$ 400,000	$ 1,800,000		$ 20,000	$ 700,000	$ 114,000	£ 75,000	$ 500,000	£ 300,000	$ 3,000	£ 2,000
Stock Issued During Period, Shares, Other (in Shares)	800,000									600,000														800,000
Stock Issued During Period, Value, Other	700,000									1,000,000														700,000
Shares Issued, Price Per Share (in Dollars per share)										$ 1.72														$ 0.87
Class of Warrant or Right, Issued																	200,000
Convertible Debt, Fair Value Disclosures																	200,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)					5.04												0.95
Percent of Company's Issued and Outstanding Share Capital																	6.14%
Dilution Rate																	2.50%
Pre-Money Valuation Minimum																	30,000,000,000
Derivative Liability													0		0	0	800,000
		1,683,000	154,000	1,741,000									0	154,000	58,000
Common Stock, Shares Authorized (in Shares)													0	74,963	0			458,621
Milestone Payments													32,000,000											8,600,000
Royalty Rate, Milestone Payments													8.50%
Licenses Revenue									100,000,000
Royalty Rate, Percent of Net Sales						5.00%	3.00%																	4.50%									1.00%
Percent of Sub-License Consideration																								18.00%
Royalty Rate Net Selling Price Of The Product																													2.00%	2.00%			1.50%
Maintenance Fee Obligation Waived								500,000
Effect on Future Cash Flows, Amount																																		$ 26,000